Top Suppliers:I want be here

131438-79-4

131438-79-4 structure
131438-79-4 structure
  • Name: Beta-Amyloid(1-40)
  • Chemical Name: amyloid beta-protein (human, 1-40) trifluoroacetate
  • CAS Number: 131438-79-4
  • Molecular Formula: C194H295N53O58S
  • Molecular Weight: 4329.867
  • Catalog: Biochemical Peptide
  • Create Date: 2018-05-30 08:00:00
  • Modify Date: 2024-01-02 13:43:13
  • β-Amyloid (1-40) is a primary protein in plaques found in the brains of patients with Alzheimer's disease.

Name amyloid beta-protein (human, 1-40) trifluoroacetate
Synonyms beta Amyloid (1-40) human
β-amyloid 40
Amyloid β-Peptide (1-40) (human)
Amyloidb-Peptide(1-40)(human)
amyloid β protein fragment 1-40
Abeta(1-40)
β-amyloid protein 40
M.W. 4329.86 C194H295N53O58S
AMYLOID B-PROTEIN FRAGMENT 1-40
SS-AMYLOID (1-40), RAT
aβ40
H-Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Gly-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH
Abeta40
Human β-amyloid peptide (1-40)
β-Amyloid (1-40)
Description β-Amyloid (1-40) is a primary protein in plaques found in the brains of patients with Alzheimer's disease.
Related Catalog
In Vitro β-Amyloid (1-40) and (1-42) are major components of senile plaque amyloids, are physiological peptides present in the brain, cerebrospinal fluid (CSF) and plasma. The levels of CSF β-Amyloid (1-40) and (1-42) show a U-shaped natural course in normal aging[1].Chronic infusion of beta-amyloid (1-40) for 14 days into the rat cerebroventricle decreased the activity of soluble protein kinase C (PKC) in the hippocampus. Subcellular translocation of PKC to membrane fraction in hippocampal slices of rats treated with beta-amyloid (1-40) is completely abolished under acute stimulation with 0.5 microM phorbol-dibutyrate (PDBu)[2].
In Vivo Chronic infusion of β-Amyloid (1-40) into rat cerebroventricle leads to deficit in spatial and non-spatial memory formation[2]. Chronic treatment of β-Amyloid (1-40) does not change lever-pressing performance significantly, but performance declined significantly 30 days after termination of the chronic daily regimen. The soluble unaggregated form of β-Amyloid (1-40), injected into the dorsal hippocampus, does not appear to have behavioral effects on performance or short-term working memory in rats, but multiple repeat injections produced performance decrements several weeks later. Repeated injection of β-Amyloid (1-40) through indwelling cannulae shows promise for development of an animal model of Alzheimer's disease[3].
Animal Admin Rats: HPLC buffer insures the β-Amyloid (1-40) does not aggregate in solution prior to injection, β-Amyloid (1-40) and vehicle are bilaterally infused into the hippocampus, 20 min before experimental sessions, in volumes of 1, 2 and 3 μL per side, at a rate of <1 μL/min. Different volumes of the 1 μM solution are used. Volumes (doses) are given in random order and at least three sham-injection sessions are interposed between β-Amyloid (1-40) or vehicle injections. All rats receive all doses of β-Amyloid (1-40) under the acute injection regimen[3].
References

[1]. Shoji M, et al. Cerebrospinal fluid Abeta40 and Abeta42: natural course and clinical usefulness. Front Biosci. 2002 Apr 1;7:d997-1006.

[2]. Cleary J, et al. Beta-amyloid(1-40) effects on behavior and memory. Brain Res. 1995 Jun 5;682(1-2):69-74.

[3]. Olariu A, et al. Memory impairment induced by chronic intracerebroventricular infusion of beta-amyloid (1-40) involves downregulation of protein kinase C. Brain Res. 2002 Dec 13;957(2):278-86.

Molecular Formula C194H295N53O58S
Molecular Weight 4329.867
Exact Mass 4329.155
Appearance powder | white
Storage condition −20°C
Water Solubility H2O: ~6 mg/mL
Personal Protective Equipment Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
RIDADR NONH for all modes of transport
WGK Germany 3